ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 089,75
-0,64%
Dow Jones
39 872,99
0,17%
DAX
18 655,25
-0,38%
Brent Oil
82,185
-0,32%
Bitcoin
69 983,13
-0,21%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) Actualités

GH

Guardant Health (GH)

Guardant Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GH
DateHeureSourceTitreSymboleSociété
21/05/202414h44Business WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
21/05/202414h44Business WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
21/05/202414h05Business WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
17/05/202414h05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
17/05/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
16/05/202414h05Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
09/05/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
09/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
09/05/202422h05Business WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/05/202422h05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
07/05/202414h00Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
22/04/202414h52Business WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
18/04/202422h05Business WireGuardant Health to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:GHGuardant Health Inc
03/04/202414h05Business WireGuardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual MeetingNASDAQ:GHGuardant Health Inc
13/03/202422h00Business WireGuardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of MedicineNASDAQ:GHGuardant Health Inc
04/03/202423h53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
01/03/202411h30Business WireNew Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening GapNASDAQ:GHGuardant Health Inc
23/02/202422h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GHGuardant Health Inc
22/02/202423h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GHGuardant Health Inc
22/02/202422h05Business WireGuardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:GHGuardant Health Inc
14/02/202401h46Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
01/02/202422h05Business WireGuardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:GHGuardant Health Inc
18/01/202423h09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
17/01/202414h05Business WireGuardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrenceNASDAQ:GHGuardant Health Inc
08/01/202415h00Business WireGuardant Health Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:GHGuardant Health Inc
08/01/202408h30PR Newswire (US)Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North AfricaNASDAQ:GHGuardant Health Inc
02/01/202417h00Business WireGuardant Health Appoints Terilyn Juarez Monroe as Chief People OfficerNASDAQ:GHGuardant Health Inc
21/12/202315h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GHGuardant Health Inc
21/12/202315h00Business WireGuardant Health Announces $90.7 Million Registered Direct Offering with Baillie GiffordNASDAQ:GHGuardant Health Inc
20/12/202322h05Business WireGuardant Health to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GHGuardant Health Inc
 Showing the most relevant articles for your search:NASDAQ:GH

Dernières Valeurs Consultées

EU
ORA
Orange
EU
SGO
Cie de SaintGobain
NASDAQ
GOOGL
Alphabet
EU
RI
Pernod Ricard
EU
LR
Legrand
EU
RNO
Renault
SPI
SP500
S&P 500
EU
HO
Thales
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
EU
AI
Air Liquide
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés